The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
β-Amyloid Accumulation Impairs Multivesicular Body Sorting by Inhibiting the Ubiquitin-Proteasome System
Open accessAbstract
Increasing evidence links intraneuronal β-amyloid (Aβ 42 ) accumulation with the pathogenesis of Alzheimer’s disease (AD). In Aβ precursor protein (APP) mutant transgenic mice and in human AD brain, progressive intraneuronal accumulation of Aβ 42 occurs especially in multivesicular bodies (MVBs). We hypothesized that this impairs the MVB sorting pathway. We used the trafficking of the epidermal growth factor receptor (EGFR) and TrkB receptor to investigate the MVB sorting pathway in cultured neurons. We report that, during EGF stimulation, APP mutant neurons demonstrated impaired inactivation, degradation, and ubiquitination of EGFR. EGFR degradation is dependent on translocation from MVB outer to inner membranes, which is regulated by the ubiquitin-proteasome system (UPS). We provide evidence that Aβ accumulation in APP mutant neurons inhibits the activities of the proteasome and deubiquitinating enzymes. These data suggest a mechanism whereby Aβ accumulation in neurons impairs the MVB sorting pathway via the UPS in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In this model, Ab accumulates along the endosomal/lysomal pathway that leads to dysfunction of multivesicular bodies, causing impairment of the ubiquitin-proteasome system, 9 which also controls the fate of NMDARs undergoing endocytic vesicular trafficking.50”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [9]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [9]
In the citing paper
“In one study, Aβ-induced abnormalities in MVB endocytic sorting were demonstrated in APP mutant neurons, which appeared to be due to impairment of the ubiquitin proteasome system (UPS; [2]).”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [2]
In the citing paper
“The study went on to provide evidence that abnormalities in MVB sorting were due to Aβ-dependent alterations in the ubiquitin-proteasome system (UPS).”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [2]
In the citing paper
“Using the well established endocytosis of the epidermal growth factor receptor (EGFR), this study demonstrated that specifically the MVB sorting pathway, and not internalization or the recycling pathway, was altered in Aβ accumulating neurons.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Self-citationMukherjee, S., Ghosh, R. K., & Maxfield, F. R. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.759 · Cited by 1,299
Receptor downregulation and multivesicular-body sorting
Katzmann, D. J., Odorizzi, G., & Emr, S. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm973 · Cited by 1,201
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991
Self-citationActivity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
The Rab5 effector EEA1 is a core component of endosome docking
Christoforidis, S., McBride, H. M., Burgoyne, R. D., & Zerial, M. (1999) · Nature · doi:10.1038/17618 · Cited by 854
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
Research works printed but not linked: 1
- (2005), Methods Mol Biol, 301, 207
Cited by
Sorted by citations
Items 201–300 of 316
Alzheimer Disease: The Role of Aβ in the Glutamatergic System
Campos‐Peña, V., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/57367 · Cited by 24
Park, H., Kim, S.-S., Kang, S., & Rhim, H. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.001 · Cited by 19
Reduced retromer function results in the accumulation of amyloid-beta oligomers
Ansell-Schultz, A., Reyes, J. F., Samuelsson, M., & Hallbeck, M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.09.003 · Cited by 18
Vrancx, C., & Annaert, W. G. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.05.007 · Cited by 18
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
Checler, F., & da Costa, C. A. (2022) · Biomolecules · doi:10.3390/biom12040559 · Cited by 19
Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease
Limone, A., Veneruso, I., D’Argenio, V., & Sarnataro, D. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30864 · Cited by 18
Chaves, E. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-076 · Cited by 18
Study of Exosomes Shed New Light on Physiology of Amyloidogenesis
van Niel, G. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0357-0 · Cited by 20
The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis
Stock, A. J., Kasus‐Jacobi, A., Wren, J. D., Sjoelund, V. H., Prestwich, G. D., & Pereira, H. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163330 · Cited by 16
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17
Self-citationOtero, M. G., Bessone, I. F., Hallberg, A. E., Cromberg, L. E., Rossi, M. C. D., Saez, T. M. M., Levi, V., Almenar‐Queralt, A., & Falzone, T. L. (2018) · Journal of Cell Science · doi:10.1242/jcs.214536 · Cited by 16
Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B)
Midani-Kurçak, J. S., Dinekov, M., Puladi, B., Arzberger, T., & Köhler, C. N. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.008 · Cited by 17
Bolognin, S., Zatta, P. F., Lorenzetto, E., Valenti, M. T., & Buffelli, M. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.008 · Cited by 17
Susaki, E. A., Kaneko-Oshikawa, C., Miyata, K., Tabata, M., Yamada, T., Oike, Y., Katagiri, H., & Nakayama, K. I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105841 · Cited by 17
Perucho, J., Casarejos, M. J., Rubio, I., Rodríguez‐Navarro, J. A., Gómez, A., Ampuero, I., Rodal, I., Solano, R. M., Carro, E., de Yébenes, J. G., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.029 · Cited by 16
Türker, F., Bharadwaj, R. A., Kleinman, J. E., Weinberger, D. R., Hyde, T. M., White, C. J., Williams, D. W., & Margolis, S. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104811 · Cited by 16
Ma, L., Ohyagi, Y., Miyoshi, K., Sakae, N., Motomura, K., Taniwaki, T., Furuya, H., Takeda, K., Tabira, T., & Kira, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0990 · Cited by 16
The therapeutic potential of the proteasome in leukaemia
McCloskey, S. M., McMullin, M. F., Walker, B., & Irvine, A. E. (2008) · Hematological Oncology · doi:10.1002/hon.848 · Cited by 16
Perdok, A., Acker, Z. P. V., Vrancx, C., Sannerud, R., Vorsters, I., Verrengia, A., Callaerts‐Vegh, Z., Creemers, E., Fernández, S. G., D’hauw, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54777-y · Cited by 18
The Nuclear Inclusion a (NIa) Protease of Turnip Mosaic Virus (TuMV) Cleaves Amyloid-β
Han, H.-E., Sellamuthu, S., Shin, B. H., Lee, Y., Song, S., Seo, J.-S., Baek, I., Bae, J., Kim, H., Yoo, Y. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015645 · Cited by 15
Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding
Lazaris, A. S., Hwang, K., Goukasian, N., Ramirez, L. M., Eastman, J. A., Blanken, A. E., Teng, E., Gylys, K. H., Cole, G. M., Saykin, A. J., et al. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000022 · Cited by 15
The Role of Aging in Alzheimer’s Disease
Kerchner, G. A., & Wyss‐Coray, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_7 · Cited by 14
Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators
Morozov, A. V., Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen’ev, M. B., Sharova, N. P., Карпов, В. Л., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160491 · Cited by 14
Hajipour, M. J., Mohammad‐Beigi, H., Nabipour, I., Mahmoudi, N., Azhdarzadeh, M., Derakhshankhah, H., Dawud, D. E., Mohammadinejad, R., & Otzen, D. E. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100983 · Cited by 14
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220031 · Cited by 15
Sharma, N. M., Haibara, A. S., Katsurada, K., Liu, X., & Patel, K. P. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.10.007 · Cited by 14
Taking STEPs Forward to Understand Fragile X Syndrome
Goebel-Goody, S. M., & Lombroso, P. J. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_12 · Cited by 14
Vasilopoulou, M. Α., Gioran, A., Theodoropoulou, M. C., Koutsaviti, A., Roussis, V., Ioannou, E., & Chondrogianni, N. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102462 · Cited by 17
Dupont, G. C., Iwanaga, J., Yilmaz, E., & Tubbs, R. S. (2019) · Lymphatic Research and Biology · doi:10.1089/lrb.2018.0079 · Cited by 13
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417586 · Cited by 13
Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model
Verheijen, B. M., Stevens, J., Gentier, R. J. G., Hekke, C. D. V. ‘., van den Hove, D., Hermes, D. J. H. P., Steinbusch, H. W. M., Ruijter, J. M., Grimm, M. O. W., Haupenthal, V. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.011 · Cited by 12
Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/393510 · Cited by 11
Frese, A., Goode, C., Zhaliazka, K., Holman, A. P., Dou, T., & Kurouski, D. (2023) · Protein Science · doi:10.1002/pro.4717 · Cited by 10
Moyano, P. M., Solà, E., Naval, M. V., Guerra-Menéndez, L., Fernández, M. D. L. C., & del Pino, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082048 · Cited by 12
Beta-amyloid oligomers: recent developments
Borutaite, V., Morkuniene, R., & Valincius, G. (2011) · bmc · doi:10.1515/bmc.2011.019 · Cited by 9
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
Gouras, G. K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00185 · Cited by 10
Self-citationImpact of Intracellular β-Amyloid in Transgenic Animals and Cell Models
Cuello, A. C., & Canneva, F. (2008) · Neurodegenerative Diseases · doi:10.1159/000113686 · Cited by 9
Jia, S., Li, Q., Rui, X., Qin, W., Zhang, W., Dou, J., & Zhang, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1730206 · Cited by 8
Matveyenka, M., Zhaliazka, K., & Kurouski, D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00277 · Cited by 8
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer’s Disease: The Path Forward
Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052981 · Cited by 9
Quantification of Amyloid Precursor Protein and Tau for the Study of Axonal Traffic Pathways
Goldsbury, C. S., Thies, E., Konzack, S., & Mandelkow, E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5024-06.2007 · Cited by 8
Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways
Eldeeb, M. A., Ragheb, M. A., Soliman, M. H., & Fahlman, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00396-0 · Cited by 9
Lower CSF amyloid-beta1–42 predicts a higher mortality rate in frontotemporal dementia
Vieira, D., Durães, J., Baldeiras, I., Santiago, B., Duro, D., Lima, M., Leitão, M. J., Tábuas-Pereira, M., & Santana, I. (2019) · Diagnostics · doi:10.3390/diagnostics9040162 · Cited by 6
Depletion of ESCRT ameliorates APP‐induced AD‐like symptoms in Drosophila
Zhuang, L., Li, C., Peng, F., Xue, E., Li, W., Sun, X., Chen, P., Zhou, Q., & Xue, L. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31035 · Cited by 6
Alzheimer’s Disease: Significant Benefit from the Yeast-Based Models
Epremyan, K. K., Mamaev, D. V., & Zvyagilskaya, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129791 · Cited by 7
Role of receptor tyrosine kinases in neurodegenerative disorders
Fu, L., & Liu, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00002-6 · Cited by 6
BIN1 in the Pursuit of Ousting the Alzheimer’s Reign: Impact on Amyloid and Tau Neuropathology
Kaur, I., Behl, T., Sundararajan, G., Panneerselvam, P., Vijayakumar, A. R., Senthilkumar, G. P., Venkatachalam, T., Jaglan, D., Yadav, S., Anwer, K., et al. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00670-3 · Cited by 6
Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116036 · Cited by 6
Therapeutic effects of a novel synthetic α-secretase
Kim, S. B., Mun, B.-R., Kim, S. Y., Elangovan, M., Park, E. J., Choi, W., & Park, W. J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1383905 · Cited by 5
Desouky, M. A., Michel, H. E., Elsherbiny, D. A., & George, M. Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123206 · Cited by 5
The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases
Hagey, D. W., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00014-x · Cited by 5
Rampérez, A., Bartolomé‐Martín, D., García-Pascual, Á., Sánchez‐Prieto, J., & Torres, M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00712 · Cited by 5
Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line
Paula-Lima, A. C., Arriagada, C., Toro, R., Cárdenas, A. M., Caviedes, R., Ferreira, S. T., & Caviedes, P. A. (2008) · Biological Research · doi:10.4067/s0716-97602008000200001 · Cited by 5
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 5
Sato, T., Ochiishi, T., Higo-Yamamoto, S., & Oishi, K. (2023) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.23-0104 · Cited by 4
Amyloid‐Like Fibrils: Origin, Structure, Properties, and Potential Technological Applications
Taboada, P., Barbosa, S., Juárez, J., Alatorre‐Meda, M., & Mosquera, V. (2013) · Wiley eBooks · doi:10.1002/9781118523063.ch12 · Cited by 4
Neuronal aging potentiates beta-amyloid generation via amyloid precursor protein endocytosisPreprint
Burrinha, T., Gomes, R. A., Terrasso, A. P., & Almeida, C. G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/616540 · Cited by 4
Self-citationNeuronal endolysosomal alterations induced by Apolipoprotein E4 emerge over time in primary neurons
Nyberg, E., Konings, S. C., Lindblom, N., Israelsson, B., Klementieva, O. L., Martinsson, I., & Gouras, G. K. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110479 · Cited by 3
Self-citationMorozov, A. V., Burov, A. V., Funikov, S. Y., Teterina, E. V., Astakhova, T. M., Erokhov, P. A., Ustyugov, A. A., & Карпов, В. Л. (2023) · Molecular Biology · doi:10.1134/s0026893323050138 · Cited by 3
Herline, K., Pauers, M. M., Lipponen, J. E., Zrzavy, M. A., Roque, C. G., McCurdy, E. P., Chung, K. M., & Hengst, U. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07586-0 · Cited by 2
Sun, L., Liu, J., Lu, M., Zhou, Y., Guo, S., Qin, Z., Wang, Z., & Sun, X. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110226 · Cited by 2
Thapa, R., Adhikari, N., Gautam, S., Sun, M., McOmie, S., Davydzenka, V., SMITH, D. R., Syring, J., Kaligis, H., Kosmicki, J. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113745 · Cited by 2
Fazli, F., Davoody, S., Vissers, N., Bordbar, S., Rahbarghazi, R., Karimipour, M., & Nasrabadi, H. T. (2026) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2026.102066 · Cited by 2
Synapse-associated neuropathological markers in Alzheimer's disease
Barrantes, F. J. (2026) · Brain · doi:10.1093/brain/awag117 · Cited by 2
Elucidation of the Role of Lipids in Late Endosomes on the Aggregation of Insulin
Joshi, R., Zhaliazka, K., Holman, A. P., & Kurouski, D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00475 · Cited by 2
Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189913 · Cited by 3
Volloch, V., & Rits‐Volloch, S. (2025) · Genes · doi:10.3390/genes16010046 · Cited by 3
Alzheimer’s disease vaccines: promises and pitfalls
Tabira, T. (2011) · Clinical Investigation · doi:10.4155/cli.11.71 · Cited by 2
The Amyloid _-Protein and Alzheimer's Disease
Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2
Ubelmann, F., Burrinha, T., & Almeida, C. G. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2629 · Cited by 2
Self-citationBanerjee, V., Oren, O., Dagan, B., Taube, R., Engel, S., & Papo, N. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00491 · Cited by 2
Ubiquitin ligases: Proteolytic signaling, protein turnover, and disease
dos Passos, P. M. S., de Correia, C. R. S. T. B., de Oliveira, C. A. B., Spagnol, V., Martins, I. F. M., & Teixeira, F. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85696-6.00010-x · Cited by 2
Ali, A., Zhaliazka, K., Holman, A. P., & Kurouski, D. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26622 · Cited by 2
Vasconcelos, B., Bird, M., Stancu, I., Terwel, D., & Dewachter, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00006-3 · Cited by 2
Davidson, K., Bano, M., Parker, D. J., Rodriguez, K., Osmulski, P. A., Gaczynska, M. E., & Pickering, A. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.23.619877 · Cited by 2
Using yeast as a model system for the genetic dissection of α-synuclein toxicity
Sancenón, V., Lee, S.-A., & Muchowski, P. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00033-6 · Cited by 1
Volloch, V., & Rits‐Volloch, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094252 · Cited by 3
Wang, B., Li, Y., Yao, T., Shen, X., Li, H., Jiang, W., Li, X., & Zhu, Z. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md00963d · Cited by 2
Amyloid Hypothesis: Molecular and Cellular Aspects of Toxicity
Kayed, R., & Lasagna‐Reeves, C. A. (2013) · Modecular medicine and medicinal · doi:10.1142/9781848167551_0001 · Cited by 2
Immunoproteasome System in Aging, Lifespan, and Age-Associated Disease
Pickering, A. M., & Miller, R. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_111 · Cited by 1
Protein structure–function continuum
Tripathi, T., & Uversky, V. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21809-5.00013-2 · Cited by 1
Neurotoxicity of amyloid β proteins
Hattori, N., Kitagawa, K., Nakayama, Y., & Inagaki, C. (2008) · Folia Pharmacologica Japonica · doi:10.1254/fpj.131.326 · Cited by 1
Natural Intracellular Consequences of Amyloid
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00003-6 · Cited by 1
Immunoproteasome System in Aging, Lifespan, and Age-Associated Disease
Pickering, A. M., & Miller, R. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_111-1 · Cited by 1
Chabrier, M. A., Neely, K. M., Castello, N. A., & LaFerla, F. M. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00001 · Cited by 1
Intracellular Amyloid β: A Modification to the Amyloid Hypothesis in Alzheimer's Disease
Zhang, Y. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch6 · Cited by 1
Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
Bharadwaj, P. (2011) · Australasian Journal of Paramedicine · Cited by 1
Discovery and validation of prostate cancer biomarkers
Jansen, F. W. (2013) · EUR Research Repository (Erasmus University Rotterdam)
Structure and Function of Stefin B Oligomers – Important Role in Amyloidogenesis
Taler‐Verčič, A., Polajnar, M., & Žerovnik, E. (2014) · InTech eBooks · doi:10.5772/57570
Zhang, Y.-Q. (2008) · UKnowledge (University of Kentucky)
Merlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.3.143
Distinct Pools of -Amyloid in Alzheimer Disease–Affected Brain
Steinerman, J. R., Irizarry, M. C., Scarmeas, N., Raju, S., Brandt, J., Albert, M., Blacker, D., Hyman, B. T., & Stern, Y. (2022) · doi:10.7916/j0pe-r896
Pathological Consequences of Aβ From Extracellular to Intraneuronal
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00004-8
Neuron-to-neuron propagation of neurodegenerative proteins; relation to degradative systems
Domert, J. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-134667
Sjödin, S. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Post-Translational Modifications in Neurodegeneration
Mamun, A. A., & Hossain, M. F. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch005
Proteostasis beyond chaperones - Auxiliary systems in the management of damaged proteins
Josefson, R. (2021) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Oligomers of α-Synuclein in the Pathogenesis of Parkinson’s Disease
Hong, D.-P., Zhou, W., Santner, A. A., & Uversky, V. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_6
Metadata
- Authors
- Almeida, C. G., Takahashi, R. H., & Gouras, G. K.
- Affiliations
- Cornell University (US)
- Corresponding author
- Gouras, Gunnar K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-04-19
- Volume
- 26
- Issue
- 16
- Pages
- 4277-4288
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6673997
- OpenAlex
- W2168538246
- Cited by
- 316
- References
- 59
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 26 · 2022: 18 · 2021: 12 · 2020: 17 · 2019: 20 · 2018: 14 · 2017: 15 · 2016: 14 · 2015: 15 · 2014: 10 · 2013: 20 · 2012: 18
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Alzheimer's Association
- American Health Assistance Foundation
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS045677, NS 045677)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- amyloid-beta deposition, multivesicular bodies, ubiquitin-proteasome system, Alzheimer's disease, epidermal growth factor receptor, TrkB receptor, receptor degradation, ubiquitination, deubiquitinase, proteasome inhibition
- MeSH terms
- Animals, Cells, Cultured, Epidermal Growth Factor, Hippocampus, Humans, Male, Mice, Transgenic, Synaptic Vesicles, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Ubiquitin, Proteasome Endopeptidase Complex, Mice, Rats, Proteasome Inhibitors, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
